Immune evasion properties of herpes simplex virus type 1 glycoprotein gC

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4253-4260

  Friedman, Harvey M ^a   Wang, Liyang ^a   Fishman, Neil O ^a   Lambris, John D ^a   Eisenberg, Roselyn J ^a   Cohen, Gary H ^a   Lubinski, John ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GENE MUTATION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS STRAIN;

EID: 0029888982     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4253-4260.1996     Document Type: Article

References (59)

1. Albrecht, J.-C., and B. Fleckenstein. 1992. New member of the multigene family of complement control proteins in herpesvirus saimiri. J. Virol. 66: 3937-3940.
2. Alcami, A., and G. L. Smith. 1992. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153-167.
3. Baucke, R. B., and P. G. Spear. 1979. Membnine proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J. Virol. 32:779-789.
4. Bielefeldt Ohmann, H., and L. A. Babiuk. 1988. Induction of receptors for complement and immunoglobulins by herpesviruses of various species. Virus Res. 9:335-342.
5. Cooper, N. R., and G. R. Nemerow. 1986. Complement-dependent mechanisms of virus neutralization, p. 139-162. In G. D. Ross (ed.), Immunobiology of the complement system. An introduction for research and clinical medicine. Academic Press, New York.
6. Daniels, C. A., T. Borsos, H. J. Rapp, R. Snyderman, and A. B. Notkins. 1970. Neutralization of sensitized virus by purified components of complement. Proc. Natl. Acad. Sci. USA 65:528-535.
7. Dubin, G., S. Basu, D. L. P. Mallory, M. Basu, R. Tal-Singer, and H. M. Friedman. 1994. Characterization of domains of herpes simplex virus type 1 glycoprolein E involved in Fc binding activity for immunoglobulin G aggregates. J. Virol. 68:2478-2486.
8. Dubin, G., N. O. Fishman, R. J. Eisenberg, G. H. Cohen, and H. M. Friedman. 1992. The role of the herpes simplex virus glycoproteins in immune evasion. Curr. Top. Microbiol. Immunol. 179:111-120.
9. Dubin, G., E. Socolof, I. Frank, and H. M. Friedman. 1991. Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J. Virol. 65:7046-7050.
10. Ebenbichler, C. F., N. M. Thielens, R. Vornhagen, P. Marschang, G. J. Arlaud, and M. P. Dierich. 1991. Human immunodeficiency virus typo 1 activates the classical pathway of complement by direct Cl binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174: 1417-1424.
11. Edens, R. E., R. J. Linhardt, C. S. Bell, and J. M. Weiler. 1994. Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. Immunopharmacology 27:145-153.
12. Eisenberg, R. J., M. Ponce de Leon, H. M. Friedman, L. Fries, M. M. Frank, J. Hastings, and G. H. Cohen. 1987. Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus type 1 and 2. Microb. Pathog. 3:423-435.
13. Frank, I., and H. M. Friedman. 1989. A novel function of the herpes simplex virus type I Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J. Virol. 63:4479-4488.
14. Friedman, H. M., G. H. Cohen, R. J. Eisenberg, C. Seidel, and D. B. Cines. 1984. Glycoprotein C of herpes simplex virus type 1 acts as a receptor for the C3b complement component on infected cells. Nature (London) 309:633-635.
15. Friedman, H. M., A. Yee, H. Diggelmann, J. C. Hastings, R. Tal-Singer, C. Seidel-Dugan, R. J. Eisenberg, and G. H. Cohen. 1989. Use of glucocorticoid inducihle promoter for the expression of herpes simplex virus type 1 glycoprotcin gC-l, a cytotoxic protein in mammalian cells. Mol. Cell Biol. 9:2303-2314.
16. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. M. van Endert, R. Tampe, P. A. Pelerson, and Y. Yang. 1995. A viral inhibitor of peptidc transporters for antigen presentation. Nature (London) 375:415-418.
17. Gerber, S. I., B. J. Belval, and B. C. Herold. 1995. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214:29-39.
18. Gerhard, W., J. Yewdell, M. E. Frankel, and R. Webster. 1981. Antigenic structure of influenza virus hacmagglutinin defined by hybridoma antibodies. Nature (London) 290:713-717.
19. Goldstein, D. J., and S. K. Weller. 1988. An ICP6::lacZ insertion mutagen is used to demonstrate that the UL52 gene of herpes simplex virus type 1 is required for virus growth and DNA synthesis. J. Virol. 62:2970-2977.
20. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5-7.
21. Gustafson, K. S., G. M. Vercellotti, C. M. Bendel, and M. K. Hosteller. 1991. Molecular mimicry in Candida albicuns. Role of an integrin analogue in adhesion of the yeast to human endothelium. J. Clin. Invest. 87:1896-1902.
22. Harris, S. L., I. Frank, A. Yee, G. H. Cohen, R. J. Eisenberg, and H. M. Friedman. 1990. Glycoprotein gC of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J. Infect. Dis. 162: 331-337.
23. Hasty, L. A., J. D. Lambris, B. A. Lessey, K. Pruksananonda, and C. R. Lyttle. 1994. Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am. J. Obstet. Gynecol. 170:168-175.
24. Herald, B. C., D. WuDunn, N. Solbys, and P. G. Spear. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1090-1098.
25. Hidaka,Y.,Y. Sakai,Y. Toh, and R. Mori. 1991. gC of HSV-1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of infected cells. J. Gen. Virol. 72:915-921.
26. Hill, A., P. Jugovic, G. Russ, J. Bennick, J. Yewdell, H. Ploegh, and D. Johnson. 1995. HSV turns of the TAP to evade host immunity. Nature (London) 375:411-415.
27. Hsu, D.-H., R. de Waal Malefyt, D. F. Fiorentino, M.-N. Dang, P. Vieira, J. DeVries, H. Spits, T. R. Mosmann, and K. W. Moore. 1990. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250: 830-832.
28. Huemer, H. P., C. Larcher, S. van Drunen Littel-van den Hurk, and L. A. Babiuk. 1993. Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host. Arch. Virol. 130:353-364.
29. Hung, S.-L., C. Peng, I. Kostavasili, H. M. Friedman, J. D. Lambris, R. J. Eisenberg, and G. H. Cohen. 1994. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with alternative complement pathway. Virology 203:299-312.
30. Hung, S.-L., S. Srinivasan, H. M. Friedman, R. J. Eisenberg, and G. H. Cohen. 1992. Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J. Virol. 66:4013-4027.
31. Isaacs, S. N., G. J. Kotwal, and B. Moss. 1992. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89:628-632.
32. Johnson, D. C., and V. Feenstra. 1987. Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J. Virol. 61:2208-2216.
33. Johnson, D. C., M. C. Frame, M. W. Ligas, A. M. Cross, and N. D. Stow. 1988. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J. Virol. 62:1347-1354.
34. Kotwal, G. J., S. N. Isaacs, R. McKenzie, M. M. Frank, and B. Moss. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827-830.
35. Kubota, Y., T. A. Gaither, J. Cason, J. J. O'Shea, and T. J. Lawley. 1987. Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells. J. Immunol. 138:1137-1142.
36. Litwin, V., M. Sandor, and C. Grose. 1990. Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology 178:263-272.
37. Lubinski, J. M., L. Wang, J. Lambris, R. Eisenberg, G. H. Cohen, and H. M. Friedman. 1995. The role of HSV-1 glycoprotein C in pathogenesis using a mucosal model of infection in guinea pigs, abstr. 81. In Abstracts of the 20th International Herpesvirus Workshop, Groningen. The Netherlands.
38. Marschang, P., J. Sodroski, R. Wurzner, and M. P. Dierich. 1995. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur. J. Immunol. 25:285-290.
39. McNearney, T. A., C. Odell, M. Holers, P. G. Spear, and J. P. Alkinson. 1987. HSV gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J. Exp. Med. 166:1525-1535.
40. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 248:1230-1234.
41. Nemerow, G. R., F. C. Jensen, and N. R. Cooper. 1982. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement. J. Clin. Invest. 70:1081-1091.
42. Ogata, M., and S. Shigeta. 1979. Appearance of immunoglobulin G Fc receptor in cultured human cells infected with varicella-zoster virus. Infect. Immun. 26:770-774.
43. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (London) 354:453-459.
44. Pircher, H., D. Moskophidis, U. Rohrer, K. Burki, H. Hengartner, and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature (London) 346:629-633.
45. Price, J., D. Turner, and C. Cepko. 1987. Lineage analysis in the vertehrate nervous system hy retrovirus-mediated gene transfer. Proc. Natt. Acad. Sci. USA 84:156-160.
46. Rother, R. P., S. A. Rollins, W. L. Fodor, J.-C. Albrecht, E. Setter, B. Fleckenstein, and S. P. Squinto. 1994. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvims saimiri. J. Virol. 68:730-737.
47. Rux, A. H., J. D. Lambris, Y. Wang, W. T. Moore, W. R. Abrams, H. M. Friedman, G. H. Cohen, and R. J. Eisenberg. 1994. Disullide bond analysis of truncated HSV gC from a baculovirus expression system, abstr. 23. In Abstracts of the 19th International Herpesvirus Workshop, Vancouver, British Columbia, Canada.
48. Sears, A. E. 1994. HSV-1 gC-depcndent attachment to C3b receptor CR1 (CD35), abstr. 7. In Abstracts of the 19th International Herpesvirus Workshop, Vancouver, British Columbia, Canada.
49. Sissons, J. G. P., M. B. A. Oldstone, and R. D. Schreiber. 1980. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. Proc. Natl. Acad. Sci. USA 77:559-562.
50. Spriggs, M. K., D. E. Hruby, C. R. Maliszewski, D. J. Pickup, J. E. Sims, R. M. L. Butler, and J. VanSlyke. 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-l binding protein. Cell 71:145-152.
51. Smiley, M. L., and H. M. Friedman. 1985. Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells. J. Virol. 55:857-861.
52. Spear, P. G. 1993. Entry of alphaherpesviruses into cells. Semin. Virol. 4:167-180.
53. Takeuchi, Y., C. D. Porter, K. M. Strahan, A. F. Preece, K. Gustafsson, F.-L. Cosset, R. A. Weiss, and M. K. L. Collins. 1996. Sensitization of cells and retroviruses to human scrum by (α1-3) galactosyltransferase. Nature (London) 39:85-88.
54. Tal-Singer, R., C. Peng, M. Ponce de Leon, W. R. Abrahms, B. W. Banfield, F. Tufaro, G. H. Cohen, and R. J. Eisenberg. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol. 69:4471-4483.
55. + T lymphocytes. Cell 77:525-535.
56. Weiler, J. M., R. E. Edens, R. J. Linhardt, and D. P. Kapelanski. 1992. Heparin and modified heparin inhibit complement activation in vivo. J. Immunol. 148:3210-3215.
57. Welsh, R. M. 1977. Host cell modification of lymphocytic choriomeningitis virus and newcastle disease virus altering viral inactivation by human complement. J. Immunol. 118:348-354.
58. Wirtz, G. H., R. A. Price, B. A. Mutchler, and R. W. Miller. 1987. The first component of complement as a constituent of human salivary sediment. Arch. Oral Biol. 32(7):505-508.
59. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.